CHARTWELL INVESTMENT PARTNERS/PA - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 191 filers reported holding HAEMONETICS CORP in Q1 2014. The put-call ratio across all filers is 3.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARTWELL INVESTMENT PARTNERS/PA ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2014$12,728,000
-24.2%
390,544
-2.0%
0.26%
-24.7%
Q4 2013$16,782,000
+2.3%
398,349
-3.1%
0.34%
-7.0%
Q3 2013$16,400,000
+11.5%
411,244
+15.6%
0.37%
-1.3%
Q2 2013$14,713,000355,8190.38%
Other shareholders
HAEMONETICS CORP shareholders Q1 2014
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders